Show simple item record

dc.contributor.advisorJones, Nora L.
dc.creatorGoff, Sara
dc.date.accessioned2021-08-23T17:58:15Z
dc.date.available2021-08-23T17:58:15Z
dc.date.issued2021
dc.identifier.urihttp://hdl.handle.net/20.500.12613/6865
dc.description.abstractHepatitis C virus (HCV) is a major public health concern with significant morbidity and mortality. New HCV infection is primarily associated with intravenous drug use. With the ongoing opioid crisis, the incidence of injection drug use and new HCV infection has risen. From 2010 to 2019, the number of estimated infections increased by 387% which is largely attributed to the opioid epidemic and injection drug use (CDC Viral Hepatitis 2019). In 2011 the treatment of HCV was revolutionized with the introduction of direct acting agents which revolutionized the treatment of HCV. Despite guidelines recommending treatment for PWID infected with chronic HCV there are a number of reasons this population is not commonly offered treatment. A growing body of literature has shown that PWID can be successfully treated and attain SVR even in the presence of ongoing drug use. This thesis was prepared by search of pertinent literature to analysis and arguments and evidence for and against the treatment of HCV in those with active injection drug use.
dc.format.extent29 pages
dc.language.isoeng
dc.publisherTemple University. Libraries
dc.relation.ispartofTheses and Dissertations
dc.rightsIN COPYRIGHT- This Rights Statement can be used for an Item that is in copyright. Using this statement implies that the organization making this Item available has determined that the Item is in copyright and either is the rights-holder, has obtained permission from the rights-holder(s) to make their Work(s) available, or makes the Item available under an exception or limitation to copyright (including Fair Use) that entitles it to make the Item available.
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/
dc.subjectEthics
dc.subjectHepatitis C
dc.subjectInjection drug use
dc.subjectUrban bioethics
dc.titleThe Ethical Considerations in the Treatment of Hepatitis C Virus in People Who Inject Drugs
dc.typeText
dc.type.genreThesis/Dissertation
dc.description.departmentUrban Bioethics
dc.relation.doihttp://dx.doi.org/10.34944/dspace/6847
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.description.degreeM.A.
dc.identifier.proqst14585
dc.date.updated2021-08-21T10:07:38Z
refterms.dateFOA2021-08-23T17:58:16Z
dc.identifier.filenameGoff_temple_0225M_14585.pdf


Files in this item

Thumbnail
Name:
Goff_temple_0225M_14585.pdf
Size:
1.192Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record